Episode 3.3 When should we use new treatments? Jada And cfDNA
Show: Thinking About Ob/Gyn
In this episode we discuss the new Jada postpartum hemorrhage device. More importantly, we discuss the process for choosing to utilize new interventions in clinical practice. Then we discuss a recent New York Times article detailing the problem of false positives in the noninvasive prenatal screening tests.
Follow us on Instagram @thinkingaboutobgyn.
More From Current Show
We talk with Dr. Jason Knight about what burnout really looks like in medicine and why a hard...
Listen Now We dig into how good stories and elegant mechanisms can seduce clinicians into using fertility and surgical “add-ons”...
Listen Now Tara Chettiar joins as we talk through what the Lindsay Clancy case surfaces about postpartum mood disorders and...
Listen Now We move from a Dolly Parton story to the very real ways policy, training, and clinical guidance shape...
Listen Now JJ Cox joins us as we talk through what actually changes when we perform cesarean delivery in patients...
Listen Now We challenge a few stubborn pieces of OB-GYN “common sense” and ask what the data actually supports, from...
Listen Now Howard Herrell and Stuart Winkler question long-standing OB-GYN habits that feel “routine” but do not add value, then...
Listen Now We follow the footnotes on a common gyn rule, then use that same evidence-first lens to question popular...
Listen Now Related Episodes
No related episodes found.
